4 years ago

Ultromics Raises $33 Million to Advance AI-Powered Cardiovascular Disease Diagnosis

  • Oxford-based healthtech startup Ultromics has raised $33 million in a Series B funding round to further develop its AI-powered echocardiography analysis solutions

  • The company's technology aims to improve the accuracy and speed of cardiovascular disease diagnosis using ultrasound images

  • The funding will be used to expand the company's reach and make its technology available to more patients globally.

      • ProblemHealthcare

      "Cardiovascular disease is the leading cause of death globally, and current diagnostic methods are often time-consuming and inaccurate."

      Solution

      "Ultromics has developed AI-powered software that analyzes echocardiograms to provide fast and accurate diagnoses of cardiovascular disease, helping doctors make better decisions and improve patient outcomes."

      Covered on